Ayman Akil
Senior Manager, A&G Consultancy – Middle East, North Africa and Turkey
Dr. Akil has more than 12 years of experience in academia, corporate R&D industries and cross-collaborations. He has specialized in strategic planning for research enterprises, including the analyses associated with university rankings. His consulting projects aim at designing and implementing strategies for various research entities to optimize their activities and processes as well as enhance their performance assessment models. Dr. Akil has implemented several national capacity building activities for upskilling researchers, academics and decision makers through targeted workshops and academies. Prior to joining Clarivate, Dr. Akil was a researcher at the Max-Planck Institute for Quantum Optics in Germany.
Latest news
Clarivate Unveils Citation Laureates 2025 – Highlighting Nobel-Class Research with Global Impact
22 Researchers Recognized, Including First Citation Laureate Based in Mainland China London, U.K. September 25, 2025: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Citation…
Clarivate Announces the India Research Excellence – Citation Awards 2025
The 10th Edition to Honor Researchers and Institutions for Pioneering Contributions to Research London, U.K. September 19, 2025. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced…
BioWorld by Clarivate Celebrates 35 Years of Trusted Biopharma and Medtech Journalism
Award-winning independent news and analysis continue to guide life sciences leaders through rapid scientific and market change London, U.K. — September 18, 2025 — BioWorld, published by Clarivate Plc (NYSE:CLVT),…